Mega Lifesciences PCL (BKK:MEGA)

Market Cap	29.64B
Revenue (ttm)	14.19B
Net Income (ttm)	1.97B
Shares Out	871.87M
EPS (ttm)	2.26
PE Ratio	15.01
Forward PE	13.27
Dividend	1.60 (4.57%)
Ex-Dividend Date	Aug 27, 2025

Volume	1,562,138
Average Volume	927,319
Open	34.75
Previous Close	35.00
Day's Range	34.00 - 35.25
52-Week Range	24.30 - 37.25
Beta	0.26
RSI	56.59
Earnings Date	Feb 20, 2026

About Mega Lifesciences PCL

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa. The company operates in three segments: Brands, Distribution, and Original Equipment Manufacture (OEM). It provides various medicines for allergies; blood circulation and memory; bone and joint; liver and digestive; diabetics; eyes, heart, and skin care; pain, sl...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1982
• Employees: 900
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: MEGA

Financial Performance

In 2024, Mega Lifesciences PCL's revenue was 15.39 billion, a decrease of -2.10% compared to the previous year's 15.72 billion. Earnings were 2.01 billion, an increase of 0.99%.